Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat

Th2 Factors May Be Involved in TiO2 NP-Induced Hepatic Inflammation

(2014) Jie Hong et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Characterization of Titanium Dioxide Nanoparticles in Food Products: Analytical Methods To Define Nanoparticles

(2014) Ruud J. B. Peters et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood-Brain and Blood-Spinal Cord Barriers

(2014) X. Wang et al.   JOURNAL OF NEUROSCIENCE

Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain

(2014) I. L. Campbell et al.   JOURNAL OF NEUROSCIENCE

Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood–brain barrier model

(2014) Josephine Labus et al.   JOURNAL OF NEUROSCIENCE METHODS

Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia

(2014) Emilie Brun et al.   Particle and Fibre Toxicology

Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats

(2014) Liesbeth Geraets et al.   Particle and Fibre Toxicology

Molecular mechanism of titanium dioxide nanoparticles-induced oxidative injury in the brain of mice

(2013) Yuguan Ze et al.   CHEMOSPHERE

Effects of sub-acute exposure to TiO2, ZnO and Al2O3nanoparticles on oxidative stress and histological changes in mouse liver and brain

(2013) Rupal Shrivastava et al.   DRUG AND CHEMICAL TOXICOLOGY

Oxidative stress increased hepatotoxicity induced by nano-titanium dioxide in BRL-3A cells and Sprague-Dawley rats

(2013) Baoyong Sha et al.   JOURNAL OF APPLIED TOXICOLOGY

Neurotoxicity and gene-expressed profile in brain-injured mice caused by exposure to titanium dioxide nanoparticles

(2013) Yuguan Ze et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Blood–brain barrier structure and function and the challenges for CNS drug delivery

(2013) N. Joan Abbott   JOURNAL OF INHERITED METABOLIC DISEASE

Titanium dioxide nanoparticles: a review of current toxicological data

(2013) Hongbo Shi et al.   Particle and Fibre Toxicology

CXCL1 Contributes to β-Amyloid-Induced Transendothelial Migration of Monocytes in Alzheimer’s Disease

(2013) Ke Zhang et al.   PLoS One

The blood-brain barrier in health and disease

(2012) Richard Daneman   ANNALS OF NEUROLOGY

The blood-brain barrier hypothesis in drug resistant epilepsy

(2012) N. Marchi et al.   BRAIN

Titanium Dioxide Nanoparticles in Food and Personal Care Products

(2012) Alex Weir et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Overview and introduction: The blood-brain barrier in health and disease

(2012) N. Joan Abbott et al.   EPILEPSIA

Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood–brain barrier penetration models

(2012) Éva Hellinger et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity

(2012) Rania Harati et al.   Journal of Neuroinflammation

P-Glycoprotein, Breast Cancer Resistance Protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during Blood–Brain Barrier Maturation: Involvement of Wnt/β-Catenin and Endothelin-1 Signaling

(2012) Rania Harati et al.   MOLECULAR PHARMACEUTICS

Tissue distribution and clearance of intravenously administered titanium dioxide (TiO2) nanoparticles

(2012) Naohide Shinohara et al.   Nanotoxicology

In vitro evidence of dysregulation of blood–brain barrier function after acute and repeated/long-term exposure to TiO2 nanoparticles

(2011) Emilie Brun et al.   BIOMATERIALS

In VitroPrimary Human and Animal Cell-Based Blood−Brain Barrier Models as a Screening Tool in Drug Discovery

(2011) Olivier Lacombe et al.   MOLECULAR PHARMACEUTICS

Tissue distribution and excretion of intravenously administered titanium dioxide nanoparticles

(2011) Guangping Xie et al.   TOXICOLOGY LETTERS

Prenatal exposure to titanium dioxide nanoparticles increases dopamine levels in the prefrontal cortex and neostriatum of mice

(2010) Yuta Takahashi et al.   JOURNAL OF TOXICOLOGICAL SCIENCES

Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier

(2010) David S. Miller   TRENDS IN PHARMACOLOGICAL SCIENCES

Oxidative stress in the brain of mice caused by translocated nanoparticulate TiO2 delivered to the abdominal cavity

(2009) Linglan Ma et al.   BIOMATERIALS

Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood–Brain Barrier

(2009) Birk Poller et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Structure and function of the blood–brain barrier

(2009) N. Joan Abbott et al.   NEUROBIOLOGY OF DISEASE

Nanosized titanium dioxide enhanced inflammatory responses in the septic brain of mouse

(2009) J.A. Shin et al.   NEUROSCIENCE

Potential neurological lesion after nasal instillation of TiO2 nanoparticles in the anatase and rutile crystal phases

(2008) J WANG et al.   TOXICOLOGY LETTERS

Comparing fate and effects of three particles of different surface properties: Nano-TiO2, pigmentary TiO2 and quartz

(2008) Ben van Ravenzwaay et al.   TOXICOLOGY LETTERS